Profil
Kevin Fitzgerald is the founder of Isogenica Ltd. which was founded in 2000, where he held the title of Chief Executive Officer from 2009 to 2013.
He also held the position of Chief Executive Officer at F-Star Biotechnologische Forschungs-.
Und Entwicklungsges MBH from 2009 to 2012.
Additionally, he was the Chief Executive Officer & Director at Activiomics Ltd., Chief Operating Officer at Altimmune UK Ltd., and Principal at Actinova Ltd. He holds a doctorate from the University of Cambridge and an MBA from the University of Aston.
Ehemalige bekannte Positionen von Kevin Fitzgerald
| Unternehmen | Position | Ende |
|---|---|---|
Activiomics Ltd.
Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Provides high value information for the pharmaceutical and biotechnology industry | Vorstandsvorsitzender | 04.03.2014 |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Präsident | 14.05.2012 |
Actinova Ltd.
Actinova Ltd. Pharmaceuticals: MajorHealth Technology Provides research and development services to the biotechonolgy sectors and also develops drugs and vaccines | Corporate Officer/Principal | - |
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Develops vaccines for mutating viruses | Geschäftsführer | - |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Gründer | - |
Ausbildung von Kevin Fitzgerald
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Aston
University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Develops vaccines for mutating viruses | Health Technology |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Commercial Services |
Actinova Ltd.
Actinova Ltd. Pharmaceuticals: MajorHealth Technology Provides research and development services to the biotechonolgy sectors and also develops drugs and vaccines | Health Technology |
Activiomics Ltd.
Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Provides high value information for the pharmaceutical and biotechnology industry | Commercial Services |
















